These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9710785)

  • 1. A novel treatment for venous leg ulcers.
    Alvarez OM; Fahey CB; Auletta MJ; Fernández-Obregón A
    J Foot Ankle Surg; 1998; 37(4):319-24. PubMed ID: 9710785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group.
    Falanga V; Margolis D; Alvarez O; Auletta M; Maggiacomo F; Altman M; Jensen J; Sabolinski M; Hardin-Young J
    Arch Dermatol; 1998 Mar; 134(3):293-300. PubMed ID: 9521027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, Prospective, Blinded-Enrollment, Head-To-Head Venous Leg Ulcer Healing Trial Comparing Living, Bioengineered Skin Graft Substitute (Apligraf) with Living, Cryopreserved, Human Skin Allograft (TheraSkin).
    Towler MA; Rush EW; Richardson MK; Williams CL
    Clin Podiatr Med Surg; 2018 Jul; 35(3):357-365. PubMed ID: 29861018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with a new human skin equivalent for healing venous leg ulcers.
    Fahey C
    J Vasc Nurs; 1998 Mar; 16(1):11-5. PubMed ID: 9764027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
    Curran MP; Plosker GL
    BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and mechanism of bilayered living human skin equivalent (HSE) in treatment of diabetic foot ulcers.
    Brem H; Young J; Tomic-Canic M; Isaacs C; Ehrlich HP
    Surg Technol Int; 2003; 11():23-31. PubMed ID: 12931279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing.
    Brem H; Balledux J; Bloom T; Kerstein MD; Hollier L
    Arch Surg; 2000 Jun; 135(6):627-34. PubMed ID: 10843357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of chronic wound treatment with the SNaP wound care system versus modern dressing protocols.
    Lerman B; Oldenbrook L; Eichstadt SL; Ryu J; Fong KD; Schubart PJ
    Plast Reconstr Surg; 2010 Oct; 126(4):1253-1261. PubMed ID: 20885246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Best-practice algorithms for the use of a bilayered living cell therapy (Apligraf) in the treatment of lower-extremity ulcers.
    Cavorsi J; Vicari F; Wirthlin DJ; Ennis W; Kirsner R; O'Connell SM; Steinberg J; Falanga V
    Wound Repair Regen; 2006; 14(2):102-9. PubMed ID: 16630097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leg ulcers: report on a multidisciplinary approach.
    Akesson H; Bjellerup M
    Acta Derm Venereol; 1995 Mar; 75(2):133-5. PubMed ID: 7604642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of a bilayered living cellular construct and a porcine collagen wound dressing in the treatment of venous leg ulcers.
    Marston WA; Sabolinski ML; Parsons NB; Kirsner RS
    Wound Repair Regen; 2014; 22(3):334-40. PubMed ID: 24628712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical and surgical therapy for advanced chronic venous insufficiency.
    Word R
    Surg Clin North Am; 2010 Dec; 90(6):1195-214. PubMed ID: 21074036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers.
    Falanga V; Sabolinski M
    Wound Repair Regen; 1999; 7(4):201-7. PubMed ID: 10781211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leg ulcers.
    Paquette D; Falanga V
    Clin Geriatr Med; 2002 Feb; 18(1):77-88, vi. PubMed ID: 11913740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-stage application of a novel decellularized dermis for treatment-resistant lower limb ulcers: positive outcomes assessed by SIAscopy, laser perfusion, and 3D imaging, with sequential timed histological analysis.
    Greaves NS; Benatar B; Baguneid M; Bayat A
    Wound Repair Regen; 2013; 21(6):813-22. PubMed ID: 24134424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful methods of treating leg ulcers. The tried and true, plus the novel and new.
    Phillips TJ
    Postgrad Med; 1999 May; 105(5):159-61, 165-6, 173-4 passim. PubMed ID: 10335328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness of a bilayered living cellular construct and an acellular fetal bovine collagen dressing in the treatment of venous leg ulcers.
    Sabolinski ML; Gibbons G
    J Comp Eff Res; 2018 Aug; 7(8):797-805. PubMed ID: 29809059
    [No Abstract]   [Full Text] [Related]  

  • 18. Etiology of leg ulcers, healing and recurrence rates in octo- and nonagenarians.
    Fassiadis N; Kapetanakis E; Law N
    Int Angiol; 2002 Jun; 21(2):193-5. PubMed ID: 12110783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic venous ulcers with sheets of cultured allogenic keratinocytes.
    Leigh IM; Purkis PE; Navsaria HA; Phillips TJ
    Br J Dermatol; 1987 Nov; 117(5):591-7. PubMed ID: 2446651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bioengineered living cell construct activates an acute wound healing response in venous leg ulcers.
    Stone RC; Stojadinovic O; Rosa AM; Ramirez HA; Badiavas E; Blumenberg M; Tomic-Canic M
    Sci Transl Med; 2017 Jan; 9(371):. PubMed ID: 28053158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.